“It is game-changing technology, and we’re excited to bring that to market” – Awais Bajwa
In this episode of Data Chats, Chris Richardson interviews Awais Bajwa founder and CEO of Ophthalytics, an applied artificial intelligence company specializing in Artificial Intelligence-based medical diagnostics.
His company is using AI to help detect diabetic retinopathy, which affects millions of people globally. And nearly 1 million people will experience blindness because of the disease each year. More importantly, there aren’t enough retina specialists who can diagnose patients and establish a treatment plan for them.
Using AI, his company is helping primary care physicians and diabetic centers detect the disease.
They discuss:
- Where Awais sources the data for his company and ensures its accuracy
- How he finds valuable feedback that informs its development
- Ways to approach the architectural side of data
Continued Learning
Data Science for Business Leaders
This course teaches you how to partner with data professionals to uncover business value, make informed decisions and solve problems. Learn More
Business-Driven Data Analysis
This course teaches a proven, repeatable approach that you can leverage across data projects and toolsets to deliver timely data analysis with actionable insights. Learn More
Author
-
The Pragmatic Editorial Team comprises a diverse team of writers, researchers, and subject matter experts. We are trained to share Pragmatic Institute’s insights and useful information to guide product, data, and design professionals on their career development journeys. Pragmatic Institute is the global leader in Product, Data, and Design training and certification programs for working professionals. Since 1993, we’ve issued over 250,000 product management and product marketing certifications to professionals at companies around the globe. For questions or inquiries, please contact [email protected].
View all posts